GlassScriptPhysician profile
Vanessa Grichine
NPI 1205288370
$6,527.55
in general payments reported to CMS, 2019-2025
23 companies · $585 in 2025
The $585 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $375 · 2021: $2,282 · 2022: $370 · 2023: $1,874 · 2024: $230 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,574 · Travel and Lodging: $970 · Entertainment: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,574.36 |
| Travel and Lodging | $970.19 |
| Entertainment | $144.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,522.33 | 2021-2022 | |
| Johnson & Johnson Vision Care, INC. | $1,439.96 | 2022-2025 | Acuvue |
| Shire North American Group INC | $369.17 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $344.58 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $324.37 | 2019-2023 | Cequa |
| Kala Pharmaceuticals, INC. | $262.92 | 2021 | |
| Sight Sciences, INC. | $248.69 | 2023-2025 | Tearcare System, Omni Surgical System |
| Glaukos Corporation | $203.75 | 2021-2024 | Radius, Photrexa |
| Novartis Pharmaceuticals Corporation | $195.21 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $188.29 | 2022-2025 | Infuse |
| Thea Pharma INC. | $186.29 | 2023 | |
| Alcon Vision LLC | $182.58 | 2019-2022 | |
| Optos, INC. | $167.44 | 2020-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Ocular Therapeutix, INC. | $163.80 | 2019-2023 | Dextenza |
| New World Medical,INC. | $147.44 | 2025 | Via360, Ahmed Glaucoma Valve, Kahook Dual Blade |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $142.53 | 2021-2022 | |
| Aerie Pharmaceuticals, INC. | $124.90 | 2020 | |
| Horizon Therapeutics Plc | $123.43 | 2021 | |
| Coopervision INC. | $64.61 | 2023-2024 | Paragon Crt, Misight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $42.76 | 2021 | |
| Eyevance Pharmaceuticals LLC | $37.83 | 2019 | |
| Carl Zeiss Meditec, INC. | $27.78 | 2019 | |
| Biotissue Holdings INC. | $16.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Grichine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.